Developer docs
API playgroundTry for free, no card

Search company profiles

TiVentures

Full company profile

uuid00057ew

Namestring
TiVentures
Legal namestring
TiVenture SA
Websiteurl
tiventures.ch
Company typeenum
Private
Founded yearint
2016
Descriptiontext

TiVentures is a Lugano-based seed-stage investment fund operating in the Italian-speaking Ticino canton of southern Switzerland. Founded in 2016 when BancaStato's Fondazione Centenario acquired 100% of Agire Invest (the investment arm of the regional innovation agency, which began investing in 2012), TiVentures invests in early-stage technology companies with high growth potential across life sciences, medical technology, high-tech, and IT sectors. The fund maintains a portfolio of 15+ companies and co-invests with institutional partners including United Ventures, Helvetica Partners, and Claves Investments.

The fund is managed by two hands-on entrepreneurs: Lorenzo Leoni (PhD biochemistry from University of Lausanne, former Assistant Professor at UCSD, serial biomedical entrepreneur) and Paolo Orsatti (PhD Microelectronics from ETH Zurich, founder of TChip Semiconductors and NemeriX, the latter acquired by Qualcomm in 2009, and founder of Oculox Technologies). Notable portfolio outcomes include Gain Therapeutics' IPO on NASDAQ Global Select Market in 2021 (ticker: GANX), exits from Sailogy (2018), 99 Technologies (2020), and a partial exit from 4BASES (2018). Portfolio companies collectively generate over CHF 35 million in annual revenue with 390+ employees and approximately 30% average annual growth.

TiVentures generates returns through equity investments and exits via IPOs and strategic acquisitions. Its go-to-market is relationship-driven, leveraging the personal networks of its managing partners, the TiVenture Club business angels network (established 2017), institutional co-investors, and collaborations with Agire, the State Government, and local universities. In 2022, parent BancaStato injected an additional CHF 5 million into the fund to support continued investment activity.

Short descriptiontext

TiVentures is a Lugano-based seed investment fund, wholly owned by Fondazione Centenario Banca Stato, that deploys capital and hands-on mentoring into early-stage technology companies across life sciences, medical, high-tech, and IT sectors in southern Switzerland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLugano, Switzerland
HQ citystring
Lugano
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
seed investment fund, early-stage venture capital, technology startup funding, life sciences investing, portfolio company mentorship
Industry3 codes
1Impact Investment & Development Investment Funds
CodeBPADACAOPrimaryYes
2Development Finance & Blended Finance Facilities
CodeBPADAOADPrimaryNo
3Independent Venture Debt Funds / Platforms
CodeFSANAIABPrimaryNo
NAICS code2 codes
  • Other Investment Pools and Funds5259
  • Portfolio Management and Investment Advice52394
SIC code2 codes
  • Investment Advice6282
  • Services-Management Consulting Services8742
Product category
Seed-stage venture capital investing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns / Fund Management
TypeTransaction Fee
Description

TiVentures generates returns through equity investments in early-stage companies. The fund is owned by Fondazione Centenario Banca Stato and earns returns through successful exits of portfolio companies, including IPOs (Gain Therapeutics on NASDAQ) and strategic acquisitions.

tiventures.ch
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

TiVentures is a privately held seed investment fund that provides equity capital, hands-on coaching, and access to international expert networks to early-stage technology companies in southern Switzerland. Owned by Fondazione Centenario Banca Stato and managed by hands-on entrepreneurs, the fund invests across life sciences, medical technology, high-tech, and IT sectors, primarily in Ticino-based companies, with a portfolio exceeding 15 active investments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Portfolio companies with aggregate revenues exceeding CHF 35M and 30% average annual growth rate
+2 more records
Product and service2 records
1TiVentures Seed Investment Fund
CategorySeed-stage venture capital investing
Description

Privately held seed investment fund that provides equity capital, hands-on coaching, and access to an international expert network to early-stage technology companies in southern Switzerland, with a diversified portfolio in life sciences, medical, high-tech, and IT sectors.

2TiVenture Club (Business Angels Club)
CategoryCo-investor network / Business angels club
Description

Business angels club created by TiVentures that broadens the pool of private co-investors providing additional capital and mentorship to TiVentures' portfolio companies.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TiVentures collaborates with Agire, the Innovation Agency of southern Switzerland. Agire Invest was the predecessor of TiVentures, started investing in early innovative companies in 2012. The organizations continue to collaborate on supporting the growth, diversification and innovation of the Ticino economy.

Strategic tierStrategicTypeTechnology or Integration
Description

Delvitech (TiVentures portfolio company) partnered with Velankani for production partnership. The Indian group manufactures the whole machine structure except for the Optical Head, which continues to be produced in Switzerland. This partnership supports Delvitech's global expansion with cost-effective manufacturing.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Zurich-based early-stage venture capital firm focused on Swiss technology companies. Comparable as a Swiss regional seed investor pursuing similar deal flow in life sciences, IT and high-tech verticals.

2Btov Partners
TypeDirect peer
Description

European venture capital firm with offices in Zurich, Berlin and Munich, investing at seed and Series A. Comparable as a regional European early-stage investor with similar multi-sector approach.

TypeDirect peer
Description

Zurich-based pre-seed and seed fund focused on Swiss technology start-ups. Comparable as a Swiss seed investor pursuing similar early-stage opportunities across tech and life science.

TypeDirect peer
Description

Swiss seed-to-Series A fund investing in technology start-ups. Comparable as a domestic early-stage investor active across similar technology verticals and stages in Switzerland.

TypeBroad incumbent
Description

Corporate venture arm of Swisscom focusing on Swiss and European technology start-ups. Comparable as a large institutional Swiss investor active at seed and growth stages in similar tech verticals.

TypeDirect peer
Description

Italy-based early-stage venture capital firm investing in digital and tech-enabled companies. Directly comparable as a regional European seed/Series A investor and co-investor with TiVentures in xFarm.

TypeBroad incumbent
Description

Cantonal-bank-affiliated venture and start-up finance arm of Zürcher Kantonalbank. Comparable as a Swiss cantonal-bank-backed fund providing regional seed/early-stage capital, similar institutional structure to TiVentures' BancaStato ownership.

TypeDirect peer
Description

Berlin-based early-stage VC investing across European tech. Comparable as a European regional seed-stage investor targeting similar early-stage technology opportunities across multiple sectors.

TypeDirect peer
Description

Swiss venture investor with broad portfolio of European tech companies. Directly comparable as a Switzerland-based seed-stage investor with a multi-sector investment approach similar to TiVentures.

TypeDirect peer
Description

Swiss asset management and venture capital firm based in the Zurich area. Directly comparable as a fellow Swiss regional seed/growth investor and co-investor in TiVentures portfolio companies such as Delvitech Series A.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment20 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TiVentures

Seed-stage venture capital investingtiventures.ch

TiVentures is a Lugano-based seed investment fund, wholly owned by Fondazione Centenario Banca Stato, that deploys capital and hands-on mentoring into early-stage technology companies across life sciences, medical, high-tech, and IT sectors in southern Switzerland.

What TiVentures does

TiVentures is a Lugano-based seed-stage investment fund operating in the Italian-speaking Ticino canton of southern Switzerland. Founded in 2016 when BancaStato's Fondazione Centenario acquired 100% of Agire Invest (the investment arm of the regional innovation agency, which began investing in 2012), TiVentures invests in early-stage technology companies with high growth potential across life sciences, medical technology, high-tech, and IT sectors. The fund maintains a portfolio of 15+ companies and co-invests with institutional partners including United Ventures, Helvetica Partners, and Claves Investments.

The fund is managed by two hands-on entrepreneurs: Lorenzo Leoni (PhD biochemistry from University of Lausanne, former Assistant Professor at UCSD, serial biomedical entrepreneur) and Paolo Orsatti (PhD Microelectronics from ETH Zurich, founder of TChip Semiconductors and NemeriX, the latter acquired by Qualcomm in 2009, and founder of Oculox Technologies). Notable portfolio outcomes include Gain Therapeutics' IPO on NASDAQ Global Select Market in 2021 (ticker: GANX), exits from Sailogy (2018), 99 Technologies (2020), and a partial exit from 4BASES (2018). Portfolio companies collectively generate over CHF 35 million in annual revenue with 390+ employees and approximately 30% average annual growth.

TiVentures generates returns through equity investments and exits via IPOs and strategic acquisitions. Its go-to-market is relationship-driven, leveraging the personal networks of its managing partners, the TiVenture Club business angels network (established 2017), institutional co-investors, and collaborations with Agire, the State Government, and local universities. In 2022, parent BancaStato injected an additional CHF 5 million into the fund to support continued investment activity.

TiVentures firmographics

Firmographics
Name
TiVentures
Legal name
TiVenture SA
Website
https://tiventures.ch
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
101–250 employees
Short description
TiVentures is a Lugano-based seed investment fund, wholly owned by Fondazione Centenario Banca Stato, that deploys capital and hands-on mentoring into early-stage technology companies across life sciences, medical, high-tech, and IT sectors in southern Switzerland.
Ownership category
akta.pro rank

TiVentures industry classification

Industry
Product category
Seed-stage venture capital investing
NAICS
Other Investment Pools and Funds (5259), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282), Services-Management Consulting Services (8742)
akta.pro primary industry
Impact Investment & Development Investment Funds (BPADACAO)
akta.pro secondary industries
Development Finance & Blended Finance Facilities (BPADAOAD), Independent Venture Debt Funds / Platforms (FSANAIAB)

Keywords

  • Seed investment fund
  • Early-stage venture capital
  • Technology startup funding
  • Life sciences investing
  • Portfolio company mentorship

Where TiVentures is headquartered

Location

Headquarters

HQ city
Lugano
HQ country
Switzerland
HQ region
Europe

Offices1 record

Markets served

TiVentures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Investment Returns / Fund Management: TiVentures generates returns through equity investments in early-stage companies. The fund is owned by Fondazione Centenario Banca Stato and earns returns through successful exits of portfolio companies, including IPOs (Gain Therapeutics on NASDAQ) and strategic acquisitions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

TiVentures product offering

Product offering

Core offering

TiVentures is a privately held seed investment fund that provides equity capital, hands-on coaching, and access to international expert networks to early-stage technology companies in southern Switzerland. Owned by Fondazione Centenario Banca Stato and managed by hands-on entrepreneurs, the fund invests across life sciences, medical technology, high-tech, and IT sectors, primarily in Ticino-based companies, with a portfolio exceeding 15 active investments.

Differentiator

Problem solved

Functional benefit

Products and services

  • TiVentures Seed Investment Fund Privately held seed investment fund that provides equity capital, hands-on coaching, and access to an international expert network to early-stage technology companies in southern Switzerland, with a diversified portfolio in life sciences, medical, high-tech, and IT sectors.
  • TiVenture Club (Business Angels Club) Business angels club created by TiVentures that broadens the pool of private co-investors providing additional capital and mentorship to TiVentures' portfolio companies.

Quantifiable outcome

  • Portfolio companies with aggregate revenues exceeding CHF 35M and 30% average annual growth rate
  • +2 more outcomes

Companies that use TiVentures

Customer profile

Segments1 record

Ideal customer profiles1 record

TiVentures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

TiVentures partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and strategic.

  • Agire (Fondazione Agire)coreStrategic or Co-development PartnerTiVentures collaborates with Agire, the Innovation Agency of southern Switzerland. Agire Invest was the predecessor of TiVentures, started investing in early innovative companies in 2012. The organizations continue to collaborate on supporting the growth, diversification and innovation of the Ticino economy.
  • VelankanistrategicTechnology or IntegrationDelvitech (TiVentures portfolio company) partnered with Velankani for production partnership. The Indian group manufactures the whole machine structure except for the Optical Head, which continues to be produced in Switzerland. This partnership supports Delvitech's global expansion with cost-effective manufacturing.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

TiVentures competitors and assessment

Company assessment

Direct peers

  • EquityPitcher Ventures: Zurich-based early-stage venture capital firm focused on Swiss technology companies. Comparable as a Swiss regional seed investor pursuing similar deal flow in life sciences, IT and high-tech verticals.
  • Btov Partners: European venture capital firm with offices in Zurich, Berlin and Munich, investing at seed and Series A. Comparable as a regional European early-stage investor with similar multi-sector approach.
  • Wingman Ventures: Zurich-based pre-seed and seed fund focused on Swiss technology start-ups. Comparable as a Swiss seed investor pursuing similar early-stage opportunities across tech and life science.
  • Alpana Ventures: Swiss seed-to-Series A fund investing in technology start-ups. Comparable as a domestic early-stage investor active across similar technology verticals and stages in Switzerland.
  • United Ventures: Italy-based early-stage venture capital firm investing in digital and tech-enabled companies. Directly comparable as a regional European seed/Series A investor and co-investor with TiVentures in xFarm.
  • Redstone VC: Berlin-based early-stage VC investing across European tech. Comparable as a European regional seed-stage investor targeting similar early-stage technology opportunities across multiple sectors.
  • Verve Ventures: Swiss venture investor with broad portfolio of European tech companies. Directly comparable as a Switzerland-based seed-stage investor with a multi-sector investment approach similar to TiVentures.
  • Helvetica Partners: Swiss asset management and venture capital firm based in the Zurich area. Directly comparable as a fellow Swiss regional seed/growth investor and co-investor in TiVentures portfolio companies such as Delvitech Series A.

Broad incumbents

  • Swisscom Ventures: Corporate venture arm of Swisscom focusing on Swiss and European technology start-ups. Comparable as a large institutional Swiss investor active at seed and growth stages in similar tech verticals.
  • Zürcher Kantonalbank Start-up Finance: Cantonal-bank-affiliated venture and start-up finance arm of Zürcher Kantonalbank. Comparable as a Swiss cantonal-bank-backed fund providing regional seed/early-stage capital, similar institutional structure to TiVentures' BancaStato ownership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

TiVentures social profiles

Digital presence

TiVentures compliance and trust

Trust signal

Compliance1 record

TiVentures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TiVentures leadership team

Management profile

Number of profiles

Profiles5 records

TiVentures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TiVentures M&A and investment

M&A and investment

M&A

Investments20 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TiVentures

What does TiVentures do?

TiVentures is a privately held seed investment fund that provides equity capital, hands-on coaching, and access to international expert networks to early-stage technology companies in southern Switzerland. Owned by Fondazione Centenario Banca Stato and managed by hands-on entrepreneurs, the fund invests across life sciences, medical technology, high-tech, and IT sectors, primarily in Ticino-based companies, with a portfolio exceeding 15 active investments.

Is TiVentures a public or private company?

TiVentures is a private company. It is classified as corporate owned and is currently operating.

When was TiVentures founded?

TiVentures was founded in 2016. It employs 101 to 250 people.

Where is TiVentures based?

TiVentures is headquartered in Lugano, Switzerland, in the Europe region.

How does TiVentures make money?

One revenue line is on record: investment Returns / Fund Management.

Who are TiVentures's main competitors?

Direct peers on record are EquityPitcher Ventures, Btov Partners, Wingman Ventures, Alpana Ventures, United Ventures, Redstone VC, Verve Ventures and Helvetica Partners. Broad incumbents are Swisscom Ventures and Zürcher Kantonalbank Start-up Finance.

Does TiVentures have an API?

No public API is recorded for TiVentures.

What industry is TiVentures in?

TiVentures's product category is Seed-stage venture capital investing. Its primary akta.pro industry code is BPADACAO, Impact Investment & Development Investment Funds, with a secondary code of BPADAOAD, Development Finance & Blended Finance Facilities. Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chInkVivo Technologies secures CHF 1.1 millionInkVivo Technologies AG, a Swiss biotech spin-off from ETH Zurich, has closed a CHF 1.1 million pre-seed financing round led by TiVentures and Claves Investments with participation from business angels. The funding will accelerate clinical development of lead drug formulations targeting anemia and support expansion of the company's proprietary polymer-based drug formulation and delivery platform. The company is currently advancing pilot collaborations with pharmaceutical and nutraceutical partners while in active discussions with several international industry leaders.UsiInkVivo Technologies raises CHF 1.1M in pre-seed fundingInkVivo, a biotech spin-off from ETH Zurich, has closed a CHF 1.1 million pre-seed financing round led by TiVentures and Claves Investments, with participation from business angels, to advance clinical development of its polymer-based drug delivery platform. The funding will support the company's lead product targeting anemia and expand collaborations with pharmaceutical and nutraceutical partners. InkVivo's technology enables sustained drug release and improved absorption, and the startup is currently advancing two pilot collaborations while operating on a B2B model combining internal development with strategic partnerships.TiventuresTi-Ventures – High-Tech seed capitalTiVentures, a high-tech seed investment fund owned by Fondazione Centenario Banca Stato, manages a portfolio of early-stage companies in southern Switzerland. The fund has facilitated significant growth for its investees, with aggregate revenues exceeding CHF 35 million and total employment surpassing 390 people across sectors like life sciences and IT. Key recent milestones include the NASDAQ IPO of Gain Therapeutics and substantial funding rounds for portfolio companies such as xFarm and Delvitech.BigomicsBigOmics Raises $1.85M to Revolutionize Omics Data AnalyticsBigOmics Analytics SA raised $1.85 million in financing to expand its team and commercialize its governed self-service analytics platforms for life scientists. This funding round was led by TiVentures and included several other investors, coming on top of $430,000 raised earlier this year. The company aims to disrupt omics data analysis processes and accelerate scientific discovery in data-driven therapeutics and precision medicine.startupticker.chxFarm raises €3 million in Series A roundAgtech startup xFarm has closed a €3 million Series A funding round led by United Ventures SGR SpA, with participation from TiVenture. The funds will be used to consolidate the company's presence in Italy, strengthen its technology platform with AI and blockchain capabilities, and expand into international markets across Europe, South America, and Africa. Founded in 2018 in Manno, Switzerland, xFarm offers a SaaS platform designed to facilitate farm digitalization, data collection, and agricultural traceability.